This article is more than 5 years old. Information may no longer be current.

VIDEO: LipiFlow treatment addresses persistent MGD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ANAHEIM, Calif. – Leslie O’Dell, OD, said that meibomian gland dysfunction (MGD) is the cause of symptoms and clinical findings in 86% of her patients, so she uses TearScience’s LipiView and LipiFlow technology to image and treat the meibomian glands. She said here at the American Academy of Optometry, “Results from a single 12-minute treatment in my office can last up to 12 months and sometimes even longer. There’s a big value … to my patients who have been on multiple treatments without success.”